In Brief: CardioThoracic Systems
This article was originally published in The Gray Sheet
Executive Summary
CardioThoracic Systems: Firm launches POEM (patency, outcomes and economics of MIDCAB) multicenter study to compare minimally invasive direct coronary artery bypass (MIDCAB) with conventional coronary artery bypass graft procedures. Data from two large single center studies presented at the Transcatheter Cardiovascular Therapeutics conference in Washington, D.C. the week of Sept. 22 demonstrated patency of 98% for the MIDCAB procedure, the company says. CTS expects the data "to be strengthened" by the POEM results, Richard Ferrari, CTS president and CEO, said...